These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 24149443

  • 1. Continuous glucose monitoring in children with glycogen storage disease type I.
    Kasapkara ÇS, Cinasal Demir G, Hasanoğlu A, Tümer L.
    Eur J Clin Nutr; 2014 Jan; 68(1):101-5. PubMed ID: 24149443
    [Abstract] [Full Text] [Related]

  • 2. Continuous glucose monitoring in children with glycogen storage disease type I.
    Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M.
    J Inherit Metab Dis; 2001 Dec; 24(8):863-9. PubMed ID: 11916320
    [Abstract] [Full Text] [Related]

  • 3. Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational study.
    Overduin RJ, Venema A, Lubout CMA, Fokkert-Wilts MJ, De Boer F, Schreuder AB, Rossi A, Derks TGJ.
    Mol Genet Metab; 2024 Dec; 143(1-2):108573. PubMed ID: 39243574
    [Abstract] [Full Text] [Related]

  • 4. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using 13C-glucose breath test.
    Turki A, Stockler S, Sirrs S, Duddy K, Ho G, Elango R.
    Mol Genet Metab Rep; 2023 Mar; 34():100955. PubMed ID: 36632325
    [Abstract] [Full Text] [Related]

  • 5. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.
    Kaiser N, Gautschi M, Bosanska L, Meienberg F, Baumgartner MR, Spinas GA, Hochuli M.
    Mol Genet Metab; 2019 Apr; 126(4):355-361. PubMed ID: 30846352
    [Abstract] [Full Text] [Related]

  • 6. Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
    Kasapkara CS, Tümer L, Okur I, Eminoğlu T, Ezgü FS, Hasanoğlu A.
    Turk J Pediatr; 2012 Apr; 54(1):35-7. PubMed ID: 22397040
    [Abstract] [Full Text] [Related]

  • 7. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
    Correia CE, Bhattacharya K, Lee PJ, Shuster JJ, Theriaque DW, Shankar MN, Smit GP, Weinstein DA.
    Am J Clin Nutr; 2008 Nov; 88(5):1272-6. PubMed ID: 18996862
    [Abstract] [Full Text] [Related]

  • 8. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY, Matern D, Mansfield BC, Chen YT.
    Curr Mol Med; 2002 Mar; 2(2):121-43. PubMed ID: 11949931
    [Abstract] [Full Text] [Related]

  • 9. Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.
    Turki A, Stockler S, Sirrs S, Salvarinova R, Ho G, Branov J, Rosen-Heath A, Bosdet T, Elango R.
    Mol Genet Metab Rep; 2022 Jun; 31():100880. PubMed ID: 35585965
    [Abstract] [Full Text] [Related]

  • 10. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
    Nagasaka H, Hirano K, Ohtake A, Miida T, Takatani T, Murayama K, Yorifuji T, Kobayashi K, Kanazawa M, Ogawa A, Takayanagi M.
    Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455
    [Abstract] [Full Text] [Related]

  • 11. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI, Crigler JF.
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [Abstract] [Full Text] [Related]

  • 12. Sustained high plasma mannose less sensitive to fluctuating blood glucose in glycogen storage disease type Ia children.
    Nagasaka H, Yorifuji T, Bandsma RH, Takatani T, Asano H, Mochizuki H, Takuwa M, Tsukahara H, Inui A, Tsunoda T, Komatsu H, Hiejima E, Fujisawa T, Hirano K, Miida T, Ohtake A, Taguchi T, Miwa I.
    J Inherit Metab Dis; 2013 Jan; 36(1):75-81. PubMed ID: 22971957
    [Abstract] [Full Text] [Related]

  • 13. Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study.
    Chan YC, Liu KM, Chen CL, Ong AD, Lin CC, Yong CC, Tsai PC, Lu LS, Wu JY.
    Orphanet J Rare Dis; 2021 Oct 11; 16(1):423. PubMed ID: 34635148
    [Abstract] [Full Text] [Related]

  • 14. Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study.
    Shao YX, Liang CL, Su YY, Lin YT, Lu ZK, Lin RZ, Zhou ZZ, Zeng CH, Tao CY, Liu ZC, Zhang W, Liu L.
    Orphanet J Rare Dis; 2024 Apr 11; 19(1):155. PubMed ID: 38605407
    [Abstract] [Full Text] [Related]

  • 15. [Heterogeneous phenotypes in Chinese glycogen storage disease type Ia patients with homozygous G727T mutation].
    Qiu ZQ, Wei M, Liu G, Liu GY.
    Zhonghua Er Ke Za Zhi; 2003 Apr 11; 41(4):252-5. PubMed ID: 14754525
    [Abstract] [Full Text] [Related]

  • 16. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A, Venema A, Haarsma P, Feldbrugge L, Burghard R, Rodriguez-Buritica D, Parenti G, Oosterveer MH, Derks TGJ.
    J Clin Endocrinol Metab; 2022 Aug 18; 107(9):e3612-e3623. PubMed ID: 35786777
    [Abstract] [Full Text] [Related]

  • 17. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.
    Shah KK, O'Dell SD.
    J Hum Nutr Diet; 2013 Aug 18; 26(4):329-39. PubMed ID: 23294025
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
    La Rose AM, Bazioti V, Hoogerland JA, Svendsen AF, Groenen AG, van Faassen M, Rutten MGS, Kloosterhuis NJ, Dethmers-Ausema B, Nijland JH, Mithieux G, Rajas F, Kuipers F, Lukens MV, Soehnlein O, Oosterveer MH, Westerterp M.
    Mol Metab; 2021 Nov 18; 53():101265. PubMed ID: 34091064
    [Abstract] [Full Text] [Related]

  • 19. Role of continuous glucose monitoring in the management of glycogen storage disorders.
    Herbert M, Pendyal S, Rairikar M, Halaby C, Benjamin RW, Kishnani PS.
    J Inherit Metab Dis; 2018 Nov 18; 41(6):917-927. PubMed ID: 29802555
    [Abstract] [Full Text] [Related]

  • 20. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T, Slonim AE.
    J Am Diet Assoc; 1993 Dec 18; 93(12):1423-30. PubMed ID: 8245377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.